Startup Skyhawk Therapeutics wants to fix RNA splicing gone awry - STAT

Startup Skyhawk Therapeutics wants to fix RNA splicing gone awry - STAT

STAT Plus: Startup Spotlight: Backing from a Disney and a duke propels Skyhawk Therapeutics toward ‘splicing’ therapies

By KATE SHERIDAN

ALEX HOGAN/STAT

With backing from a Disney and a duke, Skyhawk is looking to develop drugs to control that splicing — governing the way cells work at a basic level.

READ MORE